Thrombosis of the portal venous system

Journal of Ultrasound

Volumn 10, Issue 1, 2007, Pages 12-21

  Sacerdoti, D ^a   Serianni, G ^a   Gaiani, S ^a   Bolognesi, M ^a   Bombonato, G ^a   Gatta, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Hepatic cirrhosis.; Portal hypertension; Portal vein thrombosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICOAGULANT PROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; NITRIC ACID DERIVATIVE; ORAL CONTRACEPTIVE AGENT; SCLEROSING AGENT;

ABDOMINAL SURGERY; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; GENE MUTATION; GENETIC DISORDER; HUMAN; INFECTION; INTESTINE NECROSIS; LIGATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MYELOPROLIFERATIVE DISORDER; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; RECANALIZATION; RISK FACTOR; SCLEROTHERAPY; THROMBOPHILIA;

EID: 34250790652     PISSN: 19713495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jus.2007.02.007     Document Type: Article

References (58)

1. Lautt W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: the hepatic buffer response. Am J Physiol 249 (1985) G549-G556
2. Gerunda G.E., Bolognesi M., Neri D., et al. Preoperative selective portal vein embolization [PSPVE] before major hepatic resection. Effectiveness of Doppler estimation of hepatic blood flow to predict the hypertrophy rate of non-embolized liver segments. Hepatogastroenterology 49 (2002) 1405-1411
3. Ogren M., Bergqvist D., Bjorck M., Acosta S., Eriksson H., and Sternby N.H. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12 (2006) 2115-2119
4. Denninger M.H., Chait Y., Casadevall N., et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31 (2000) 587-591
5. Primignani M., Martinelli I., Bucciarelli P., et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41 (2005) 603-608
6. Bertina R.M., Koeleman B.P., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
7. Zoller B., Holm J., Svensson P., and Dahlback B. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene [APC-resistance] and/or inherited protein S deficiency. Thromb Haemost 75 (1996) 270-274
8. Mahmoud A.E., Elias E., Beauchamp N., and Wilde J.T. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 40 (1997) 798-800
9. den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., and Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80 (1998) 874-877
10. Godeau B., Leroy-Matheron C., Gouault-Heilmann M., and Schaeffer A. A case of portal vein thrombosis associated with protein S deficiency. J Hepatol 18 (1993) 258
11. Prignet J.M., Duval J.L., Raynard B., et al. Portal vein thrombosis and rupture of the esophagus secondary to a barotrauma. Gastroenterol Clin Biol 20 (1996) 103-105
12. Zigrossi P., Campanini M., Bordin G., et al. Portal and mesenteric thrombosis in protein S [pS] deficiency. Am J Gastroenterol 91 (1996) 163-165
13. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120 (2001) 490-497
14. Valla D., Casadevall N., Huisse M.G., et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94 (1988) 1063-1069
15. Trum J.W., Valla D., Cohen G., Degott C., Rueff B., and Santoni P. Bacteroides bacteremia of undetermined origin: strong association with portal vein thrombosis and cryptogenic pylephlebitis. Eur J Gastroenterol Hepatol 5 (1993) 655-659
16. Talbot R.W., Heppell J., Dozois R.R., and Beart Jr. R.W. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61 (1986) 140-145
17. Neidballa R.G. A large spontaneous portacaval shunt. Arch Intern Med 117 (1966) 54-56
18. Bernades P., Baetz A., Levy P., Belghiti J., Menu Y., and Fekete F. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci 37 (1992) 340-346
19. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54 (2005) 691-697
20. Ruol A., Finucci G.F., and Sacerdoti D. Le trombosi venose del distretto circolatorio portale. Medicina Clinica. Diagnostica e terapia 7 (1993) 775-792
21. Erkan O., Bozday A.M., Disibeyaz S., et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 17 (2005) 339-343
22. Mangia A., Villani M.R., Cappucci G., et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 17 (2005) 745-751
23. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40 (2004) 736-741
24. Fimognari F.L., De Santis A., Piccheri C., et al. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 146 (2005) 238-243
25. Webb L.J., and Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 48 (1979) 627-639
26. Merkel C., Bolognesi M., Bellon S., et al. A long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. J Hepatol 15 (1992) 299-303
27. Webster G.J., Burroughs A.K., and Riordan S.M. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 21 (2005) 1-9
28. Hagimoto T., Seo M., Okada M., et al. Portal vein thrombosis successfully treated with a colectomy in active ulcerative colitis: report of a case. Dis Colon Rectum 44 (2001) 587-590
29. Maddrey W.C., Boyer J.L., Sen N.N., Thomas J., Basu A.K., and Iber F.L. Plasma volume expansion in portal hypertension. John Hopkins Med J 125 (1969) 171-183
30. De Franchis R., and Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5 (2001) 645-663
31. Nonami T., Yokoyama I., Iwatsuki S., and Starzl T.E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 6 (1992) 1195-1198
32. Jamieson N.V. Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation 15 69 (2000) 1772-1774
33. Miller V.E., and Berland L.L. Pulsed Doppler duplex sonography and CT of portal vein thrombosis. AJR Am J Roentgenol 145 (1985) 73-76
34. Scoutt L.M., Zawin M.L., and Taylor K.J. Doppler US. Part II. Clinical applications. Radiology 174 (1990) 309-319
35. Marshall M.M., Beese R.C., Muiesan P., Sarma D.I., O'Grady J., and Sidhu P.S. Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. Clin Radiol 57 (2002) 377-383
36. Bach A.M., Hann L.E., Brown K.T., et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201 (1996) 149-154
37. Chaffanjon P.C., Brichon P.Y., Ranchoup Y., Gressin R., and Sotto J.J. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging. World J Surg 22 (1998) 1082-1086
38. Ricci P., Cantisani V., Biancari F., et al. Contrast-enhanced color Doppler US in malignant portal vein thrombosis. Acta Radiol 41 (2000) 470-473
39. Sacerdoti D., Bolognesi M., Bombonato G.C., Merkel C., and Gatta A. Pathophysiology of arterial Doppler parameters in portal hypertension. Ultrasound Med Biol 26 Suppl. B (2000) A120
40. Sacerdoti D., Merkel C., Bolognesi M., Amodio P., Angeli P., and Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 108 (1995) 1152-1158
41. Bolognesi M., Sacerdoti D., Merkel C., et al. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. Hepatology 23 (1996) 1035-1040
42. Kreft B., Strunk H., Flacke S., Wolff M., et al. Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology 216 (2000) 86-92
43. Cheng Y.F., Chen C.L., Huang T.L., et al. Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation. Clin Transpl 18 (2004) 390-394
44. Bajaj J.S., Bhattacharjee J., and Sarin S.K. Coagulation profile and platelet function in patients with portal extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol 16 (2001) 595-596
45. Chait Y., Condat B., Cazals-Hatem D., et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 129 (2005) 553-560
46. Fonkalsrud E.W., Myers N.A., and Robinson M.J. Management of extrahepatic portal hypertension in children. Ann Surg 180 (1974) 487-493
47. Janssen H.L., Wijnhoud A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49 (2001) 720-724
48. Cheong J.Y., Lee K.M., Cho S.W., et al. Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res 32 (2005) 127-133
49. Georgiades C.S., Hong K., D'Angelo M., and Geschwind J.F. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 1653-1659
50. Baril N., Wren S., Radin R., Ralls P., and Stain S. The role of anticoagulation in pylephlebitis. Am J Surg 172 (1996) 449-452
51. Condat B., Pessione F., Helene Denninger M., Hillaire S., and Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32 (2000) 466-470
52. Blum U., Haag K., Rossle M., et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195 (1995) 153-157
53. Senzolo M., Tibbals J., Cholongitas E., Triantos C.K., Burroughs A.K., and Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 23 (2006) 767-775
54. Klempnauer J., Grothues F., Bektas H., and Pichlmayr R. Results of portal thrombectomy and splanchnic thrombolysis for the surgical management of acute mesentericoportal thrombosis. Br J Surg 84 (1997) 129-132
55. Hollingshead M., Burke C.T., Mauro M.A., Weeks S.M., Dixon R.G., and Jaques P.F. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 651-661
56. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
57. Charco R., Fuster J., Fondevila C., Ferrer J., Mans E., and Garcia-Valdecasas J.C. Portal vein thrombosis in liver transplantation. Transplant Proc 37 (2005) 3904-3905
58. Gimeno F.A., Calvo J., Loinaz C., et al. Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc 37 (2005) 3899-3903